Oncolytics Biotech Inc ONCY

Immugene doses first patient with Virus- CAR-T

[askretka]

https://ca.finance.yahoo.com/news/imugene-thrilled-first-patient-dosed-200000830.html

 

Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive the company has marked a milestone with the start of its Phase 1 clinical trial for onCARlyti...

It's possible this could help drive competition and get a deal
for our Pelareorep/ CAR-T?

 

[fox7mf]

Imugene. Yes they're competition, but competition that is ph1 clinical trials, whereas ONCY is ph3 with perhaps AA. So, we are yrs ahead & have the better therapy...now....but with Coffey at the helm for BD, will Pela ever get to a major who can get it to market? Oncy was caught up to and surpassed in mBC, it seems. Will Coffey finally NOT let investors down? Stay tuned...cue the

[askretka]

Fox  just to clarify.  Pelareorep hasn't done anything in CAR-T yet. We don't even have a P1 there yet. Immugene is the first in the world here. But Pancreatic looks amazing, but it may spur more interest in our Virus CAR-T program.  Cheers!!!!!!!!!!!!!!!!!!!!!!!!

[fox7mf]

Yes yes, I know...I'm just stirring the pot. Good luck everyone!!!

[Azzak34]

Oof, that's embarrassing !!! Little guy doesn't get it. 

[Buckhenry]

We should hear something next week or next or next......  always the bridesmaid... never the bride....

[Azzak34]

Well we will hear something next week. It's the quarterly call. You, you're good at this!! 

[Peladawn]

We’ll hear an update on what fox has been cryin and moanin about for 3 months...the pancan phase 111.....logic says the market should like this news and we should see a healthy surge in our share price.....but, well, logic seldom seems to apply with the way oncy trades